Why one footnote in a 10-K could fundamentally change how investors interpret innovation.
Table of Contents
- Introduction
- A Quick History of IRC §174 and §174A
- The Cash Flow Story Is Obvious
- The Accounting Story Is More Interesting
- The Financial Statements Can Look Strange
- Effective Tax Rates Can Become Misleading
- The Leadership Paradox
- Why Investors Should Care
- What Every CFO Should Ask After Reading the Tax Footnote
- Frequently Asked Questions
- Final Thoughts
Introduction
On July 4, 2025, the One Big Beautiful Bill Act (OBBBA) fundamentally changed the U.S. tax treatment of domestic research and development expenditures.
Most headlines focused on one message:
Domestic R&D can once again be deducted immediately.
While that is certainly true, the accounting implications are arguably even more interesting.
The change affects far more than tax returns. It influences deferred taxes, reported effective tax rates, earnings volatility, cash flow, valuation models, capital allocation decisions, and even how investors interpret corporate innovation.
For finance professionals, the story is not simply about paying less tax.
It is about understanding why tax expense, cash taxes, and accounting earnings may suddenly tell completely different stories.
A Quick History of IRC §174 and §174A
Beginning with tax years after December 31, 2021, the Tax Cuts and Jobs Act required U.S. companies to capitalize and amortize domestic research expenditures over five years instead of deducting them immediately.
Foreign R&D became even less favorable, requiring fifteen-year amortization.
For many technology companies, manufacturers, pharmaceutical businesses, software developers, and engineering firms, this dramatically increased taxable income while reducing operating cash flow.
The OBBBA largely reverses that policy.
Beginning with tax years after December 31, 2024, domestic research expenditures once again qualify for immediate deduction through IRC §174A, while foreign research generally continues to require fifteen-year amortization. The legislation also provides transition rules allowing recovery of previously capitalized domestic R&D under certain circumstances.
Key Takeaway
The OBBBA is not simply a tax law. It changes the way financial statements tell the story of innovation.
The Cash Flow Story Is Obvious
Suppose a company spends:
$100 million on qualifying domestic R&D.
Under the previous rules
| Item | Amount |
|---|---|
| Immediate deduction | $20 million |
| Capitalized | $80 million |
| Current taxes | Higher |
| Operating cash flow | Lower |
Under the new rules
| Item | Amount |
|---|---|
| Immediate deduction | $100 million |
| Capitalized | $0 |
| Current taxes | Lower |
| Operating cash flow | Higher |
That alone can materially improve liquidity.
The Accounting Story Is More Interesting
Now assume the company had already accumulated deferred tax assets related to capitalized domestic R&D.
Those deferred tax assets exist because accounting recognizes future tax deductions that have not yet occurred.
Using our simplified example:
Remaining capitalized R&D
$80 million
Deferred tax asset
$80 million × 21% = $16.8 million
That deferred tax asset was perfectly reasonable under the old law.
But once Congress restored immediate expensing through IRC §174A, those future deductions effectively disappeared.
The deferred tax asset therefore must be reversed.
Importantly, this adjustment flows through tax expense, not cash.
It is an accounting remeasurement under ASC 740.
Figure 1. Simplified illustration of how the One Big Beautiful Bill Act (OBBBA) changes deferred tax accounting, current tax expense, and reported financial statement outcomes following the reinstatement of immediate domestic R&D expensing under IRC §174A.
The Financial Statements Can Tell a Very Different Story
The figure above illustrates one simplified example of how the OBBBA changes the accounting picture.
Under the previous rules, a company investing $100 million in qualifying domestic R&D could deduct only one-fifth of that expenditure in the first year. The remaining $80 million became a future tax deduction, creating a deferred tax asset of $16.8 million (assuming a 21% federal corporate tax rate).
Once the OBBBA restored immediate expensing through IRC §174A, that future deduction no longer existed. As a result, the deferred tax asset created under the previous rules must be reversed. Although this adjustment is non-cash, it flows through tax expense under ASC 740 and therefore affects reported earnings.
This creates an important distinction between tax expense, cash taxes, and net income.
A reader focusing only on the effective tax rate could mistakenly conclude that the company experienced a deterioration in tax performance, when in reality the adjustment simply reflects the remeasurement of deferred tax balances following a legislative change.
The cash economics of the business may have improved considerably through lower current taxes and stronger operating cash flow even though reported tax expense includes a one-time accounting adjustment.
That is why sophisticated investors separate:
- Current tax expense
- Deferred tax expense
- Cash taxes paid
- Temporary differences
- Permanent differences
- One-time legislative adjustments
Effective Tax Rates Can Become Misleading
Many investors instinctively calculate:
Tax Expense ÷ Pre-tax Income
Most years, that provides a reasonable approximation.
Major tax legislation changes everything.
Deferred tax remeasurements, valuation allowance adjustments, uncertain tax positions, and transition provisions can materially distort reported tax expense.
Cash taxes may actually decline while reported tax expense temporarily increases.
Understanding that distinction separates financial statement readers from financial statement analysts.
The Leadership Paradox
Here lies the interesting contradiction.
The OBBBA strongly encourages companies to invest in innovation.
Yet accounting standards still require most internally generated intangible assets to disappear into the income statement instead of appearing on the balance sheet.
Examples include:
- Proprietary software
- Artificial intelligence models
- Large language models
- Internal automation platforms
- Machine learning algorithms
- Data assets
- Customer knowledge
- Internal operating procedures
These assets often generate value for years, yet remain largely invisible in traditional financial statements.
Why Investors Should Care
Financial statements increasingly require interpretation.
A company investing heavily in domestic R&D may report:
- Lower taxable income
- Higher operating cash flow
- Volatile effective tax rates
- Deferred tax adjustments
- Lower reported earnings
- Or even higher reported earnings
…without any deterioration in the underlying business.
Accounting numbers increasingly require context.
What Every CFO Should Ask After Reading the Tax Footnote
1. Do our financial statements reflect our company’s true value creation?
Many of today’s most valuable assets never appear on the balance sheet.
How are management and investors measuring their return?
2. Are we measuring innovation as an expense or as an investment?
Software, automation, AI, and process improvements often create value for years despite being recognized as current period expenses.
Have we developed internal KPIs to measure these investments?
3. Are we separating accounting performance from economic performance?
Finance leaders should distinguish:
- Deferred tax adjustments
- Valuation allowance changes
- Legislative impacts
- Temporary differences
- Cash taxes
None necessarily reflects deterioration in the underlying business.
4. Are we using AI and automation to improve financial insight—not just efficiency?
Modern finance teams can use AI to:
- Analyze deferred tax movements
- Summarize tax legislation
- Monitor ASC 740 impacts
- Reconcile temporary differences
- Build tax scenarios
- Forecast legislative impacts
Automation should not simply produce reports faster.
It should help finance professionals ask better questions.
5. If tax law changes tomorrow, how quickly could we quantify the impact?
Organizations relying on spreadsheets may spend weeks understanding new legislation.
Organizations with integrated finance data, automation, and scenario modeling may evaluate multiple outcomes within hours.
That capability is increasingly becoming a competitive advantage.
Frequently Asked Questions
What is IRC Section 174A?
IRC §174A permanently restores immediate expensing for qualifying domestic research and experimental expenditures beginning with tax years after December 31, 2024.
What happens to deferred tax assets after a tax law change?
Deferred tax assets and liabilities must generally be remeasured using the tax law expected to apply when temporary differences reverse.
Why is tax expense different from cash taxes?
Tax expense includes both current taxes and deferred taxes.
Cash taxes represent actual payments made to tax authorities.
The two amounts are often very different.
Why does ASC 740 matter?
ASC 740 governs income tax accounting under U.S. GAAP, including deferred taxes, valuation allowances, uncertain tax positions, and changes in tax law.
Can an effective tax rate exceed 100%?
Yes.
One-time deferred tax adjustments or valuation allowance changes can temporarily produce effective tax rates above 100% without corresponding cash tax payments.
Final Thoughts
The One Big Beautiful Bill Act restores immediate expensing for domestic R&D, but its broader significance extends well beyond tax compliance.
It illustrates a larger shift taking place across corporate finance.
Increasingly, a company’s competitive advantage is driven by intangible assets—software, automation, artificial intelligence, proprietary processes, and institutional knowledge. Yet many of these assets remain largely invisible in traditional financial statements.
For finance leaders, the challenge is no longer simply understanding accounting standards or tax law in isolation. It is integrating financial reporting, tax strategy, automation, and data-driven decision making into a coherent view of enterprise value.
Ross A. Drapalski, CPA is a U.S. Certified Public Accountant, doctoral researcher in European private equity, and founder of Drapalski Consulting. He writes about accounting, corporate finance, AI, automation, governance, valuation, and cross-border tax strategy.
Need Help?
If your organization is evaluating the accounting or tax implications of recent U.S. tax legislation, finance transformation initiatives, or AI-enabled reporting, feel free to connect.
Contact Drapalski Consulting for advisory services in cross-border finance, financial reporting, governance, automation, and U.S. taxation.